INTRODUCTION {#sec1-1}
============

Bittern is made from marine water after extraction of salts, and its gravity is 1.3. Its major components include magnesium chloride, magnesium sulfate, potassium chloride, sodium chloride, and magnesium bromide. Bittern has long been used as a main ingredient for tofu coagulant and chemical weapons. Currently, the industrial bittern is used more prevalently than the natural one. Bittern contains various amounts of electrolyte components such as sodium and magnesium. Excess consumption may lead to electrolyte imbalances. We report a case of suicidal intake of bittern and its toxic symptoms with review from literatures.

CASE REPORT {#sec1-2}
===========

A 73-year-old woman arrived to the emergency department after an attempt suicide by taking five zolpidem pills and bittern of unknown amounts. She complained of dizziness and general weakness. There was no other past history other than hypertension. Her GCS was 13/15(E3/V4/M6). The patient was oriented to time, place and person and normal muscle power and sensory in the extremities. Her initial blood pressure was 149/94 mmHg, pulse rate 82 beats/min, respiratory rate 28 breaths/min and body temperature 36.0 °C. Electrocardiograph showed QT prolongation of 0.482 s \[[Figure 1](#F1){ref-type="fig"}\].

![Electrocardiograph shows QT interval prolongation](JETS-8-108-g001){#F1}

Complete blood counts showed white blood cell (WBC) counts 1,249/mL, hemoglobin (Hb) 16.9 g/dL and platelet counts 265,000/mL. In addition, the arterial blood gas analysis (ABGA) showed pH 7.36, PCO~2~ 35.0 mmHg, PO~2~ 68.6 mmHg, HCO~3~^2−^ 19.2 mmol/L, O~2~ saturation 92.4%, glucose 145 mg/dL, blood urea nitrogen (BUN) 13.6 mg/dL, creatinine 0.77 mg/dL, aspartate aminotransferase (AST) 49 IU/L, alanine aminotransferase (ALT) 27 IU/L, albumin 5.5 g/dL, C-reactive protein (CRP) 0.09 mg/dL, \[Na^+^\] 149 mEq/L, \[K^+^\] 4.5 mEq/L, \[Cl^−^\] 120 mEq/L and \[Mg^2+^\] 7.8 mEq/L. Zolpidem was measured as 0.12 mg/L on urinalysis and 0.94 mg/L on serum biochemistry. Brain CT taken right after the visit revealed no evidences of acute brain hemorrhage and following MRI showed no evidences of acute infarction.

Altered mentality of patient might have been due to zolpidem (0.94 mg/L) ingestion. The patient also had electrolyte imbalance. Hypernatremia and hyperchloremia were corrected by infusion of half-saline and hypermagnesemia was corrected by injection of 10% calcium gluconate 20 mL. A repeat blood test 12 h later showed decreasing levels of \[Na^+^\], \[K^+^\], \[Cl^−^\], and \[Mg^2+^\] to 144, 4.3, 120, and 3.2 mEq/L, respectively. The mental status of patient returned to normal without any sequelae.

Following further improvement of the electrolyte measurements, the patient was transferred to the general ward for conservative treatment. All electrolyte measurements returned to normal 4 days after the incident (\[Na^+^\] 138 mEq/L, \[K^+^\] 3.8 mEq/L, \[Cl^−^\] 109 mEq/L, and \[Mg^2+^\] 2.4 mEq/L). Electrocardiograph returned to normal after correcting electrolyte imbalances. The patient was transferred to the psychiatric ward for further evaluation and management of suicide attempt. The patient was discharged home 1 week after the incident.

DISCUSSION {#sec1-3}
==========

The normal content of Mg^2+^ in the body is approximately 22.6 g and 50-60% is located in the bone.\[[@ref1]\] It is one of the major intracellular divalent cations that are mostly found in the intracellular space. The normal recommended daily intake of Mg^2+^ is approximately 420 mg/day in adult men and 320 mg/day in adult women. The normal range of serum Mg^2+^ is between 1.7 and 2.3 mg/dL (0.75-0.95 mmol/L) with 80% being filtered in the glomerulus but only 3% is excreted in the urine.\[[@ref1]\] Mg^2+^ metabolic derangement is associated with diabetes mellitus, chronic renal failure, nephrolithiasis, osteoporosis, aplastic osteopathy, and cardiovascular diseases.\[[@ref2]\] Hypermagnesemia commonly occurs as a result of the overdosing of magnesium salts or magnesium-containing drugs; this is notable in patients with renal function insufficiency. The clinical presentation of magnesium poisoning depends on the magnesium serum concentration. A level of 5-8 mEq/L may result in nausea, flushing, headache, hyporeflexia, and lethargy. A level of 9-12 mEq/L may result in somnolence; loss of deep tendon reflexes; prolongation of QRS, PR, and QT intervals; bradycardia; and hypotension. A level above 15 mEq/L may result in complete heart block, respiratory paralysis, coma and shock. Asystole leading to death may occur in patients with \[Mg^2+^\] of \>20 mEq/L.\[[@ref3][@ref4][@ref5][@ref6]\]

Following a comprehensive history taking and serum biochemistry, patients with bittern poisoning should receive adequate fluid infusion and correction of electrolyte imbalances. Magnesium derangement should also be corrected with injections of calcium gluconate. Diuretics or dialysis are recommended for patients with renal failure. As evident in the case reported, early diagnosis and treatment is essential for improvement of the patient\'s condition. It is mandatory to serially monitor the electrolyte levels and electrocardiograph to prevent more serious complications such as respiratory paralysis, coma, shock, or death.
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